Beckman Coulter and MeMed Extend Partnership Advancing Host Immune Response Diagnostics [Yahoo! Finance]
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Yahoo! Finance
Progress Continues on Original Collaboration to Develop a MeMed BV-Based Assay for use on Beckman Coulter Immunoassay Analyzers BREA, Calif. and HAIFA, Israel May 7, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, today announced expansion of their host immune response diagnostics partnership. Beckman Coulter is now an authorized distributor of the MeMed BV® assay , a rapid immunoassay test able to distinguish between bacterial and viral infections, and MeMed Key® , a compact immunoassay analyzer cleared to run the MeMed BV assay in the United States and Europe . This new distribution agreement complements the existing joint effort to develop a MeMed BV-based test for Beckman Coulter's family of Access Immunoassay Analyzers Symptoms of bacterial and viral infections are often clinically indistinguishable, which creates challenges for physicians when decidin
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Integrated DNA Technologies and Molecular Health Ink Commercial Partnership [Yahoo! Finance]Yahoo! Finance
- Oligonucleotide Synthesis Market is Expected to Reach $19.7 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Food and Beverage Manufacturers Can Overcome Condensation Challenges with Inkjet Printing and Laser Marking [Yahoo! Finance]Yahoo! Finance
- Blood Culture Tests Market Anticipated to Reach New Heights - the Market to Worth $8.98 Billion by 2029 - Exclusive Research Report by Arizton [Yahoo! Finance]Yahoo! Finance
- Gene Synthesis Technology and Global Markets Report 2023-2028: Technological Innovations and Implications for Healthcare, Research, and Beyond [Yahoo! Finance]Yahoo! Finance
DHR
Earnings
- 4/23/24 - Beat
DHR
Sec Filings
- 5/17/24 - Form 4
- 5/17/24 - Form 4
- 5/17/24 - Form 4
- DHR's page on the SEC website